Report Cover

Global Cancer Supportive Care Drugs Market Research Report 2022


Cancer Supportive Care Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Supportive Care Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    G-CSFs (Granulocyte-colony Stimulating Factors)
    ESAs (Erythropoiesis Stimulating Agents)
    Anti-emetics
    Bisphosphonates
    Opioids
    NSAIDs
Segment by Application
    Chemotherapy Therapy
    Radiation Therapy
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Amgen
    Johnson & Johnson
    Merck
    Roche
    Helsinn Healthcare
    Heron Pharma
    Tesaro
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Supportive Care Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 G-CSFs (Granulocyte-colony Stimulating Factors)
        1.2.3 ESAs (Erythropoiesis Stimulating Agents)
        1.2.4 Anti-emetics
        1.2.5 Bisphosphonates
        1.2.6 Opioids
        1.2.7 NSAIDs
    1.3 Market by Application
        1.3.1 Global Cancer Supportive Care Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Chemotherapy Therapy
        1.3.3 Radiation Therapy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancer Supportive Care Drugs Market Perspective (2017-2028)
    2.2 Cancer Supportive Care Drugs Growth Trends by Region
        2.2.1 Cancer Supportive Care Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancer Supportive Care Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Cancer Supportive Care Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Cancer Supportive Care Drugs Market Dynamics
        2.3.1 Cancer Supportive Care Drugs Industry Trends
        2.3.2 Cancer Supportive Care Drugs Market Drivers
        2.3.3 Cancer Supportive Care Drugs Market Challenges
        2.3.4 Cancer Supportive Care Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancer Supportive Care Drugs Players by Revenue
        3.1.1 Global Top Cancer Supportive Care Drugs Players by Revenue (2017-2022)
        3.1.2 Global Cancer Supportive Care Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Cancer Supportive Care Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancer Supportive Care Drugs Revenue
    3.4 Global Cancer Supportive Care Drugs Market Concentration Ratio
        3.4.1 Global Cancer Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Supportive Care Drugs Revenue in 2021
    3.5 Cancer Supportive Care Drugs Key Players Head office and Area Served
    3.6 Key Players Cancer Supportive Care Drugs Product Solution and Service
    3.7 Date of Enter into Cancer Supportive Care Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Supportive Care Drugs Breakdown Data by Type
    4.1 Global Cancer Supportive Care Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2023-2028)
5 Cancer Supportive Care Drugs Breakdown Data by Application
    5.1 Global Cancer Supportive Care Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Supportive Care Drugs Market Size (2017-2028)
    6.2 North America Cancer Supportive Care Drugs Market Size by Country (2017-2022)
    6.3 North America Cancer Supportive Care Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Cancer Supportive Care Drugs Market Size (2017-2028)
    7.2 Europe Cancer Supportive Care Drugs Market Size by Country (2017-2022)
    7.3 Europe Cancer Supportive Care Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancer Supportive Care Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Cancer Supportive Care Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Cancer Supportive Care Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Cancer Supportive Care Drugs Market Size (2017-2028)
    9.2 Latin America Cancer Supportive Care Drugs Market Size by Country (2017-2022)
    9.3 Latin America Cancer Supportive Care Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancer Supportive Care Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Cancer Supportive Care Drugs Introduction
        11.1.4 Amgen Revenue in Cancer Supportive Care Drugs Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Detail
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Cancer Supportive Care Drugs Introduction
        11.2.4 Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Development
    11.3 Merck
        11.3.1 Merck Company Detail
        11.3.2 Merck Business Overview
        11.3.3 Merck Cancer Supportive Care Drugs Introduction
        11.3.4 Merck Revenue in Cancer Supportive Care Drugs Business (2017-2022)
        11.3.5 Merck Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Cancer Supportive Care Drugs Introduction
        11.4.4 Roche Revenue in Cancer Supportive Care Drugs Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Helsinn Healthcare
        11.5.1 Helsinn Healthcare Company Detail
        11.5.2 Helsinn Healthcare Business Overview
        11.5.3 Helsinn Healthcare Cancer Supportive Care Drugs Introduction
        11.5.4 Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2017-2022)
        11.5.5 Helsinn Healthcare Recent Development
    11.6 Heron Pharma
        11.6.1 Heron Pharma Company Detail
        11.6.2 Heron Pharma Business Overview
        11.6.3 Heron Pharma Cancer Supportive Care Drugs Introduction
        11.6.4 Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2017-2022)
        11.6.5 Heron Pharma Recent Development
    11.7 Tesaro
        11.7.1 Tesaro Company Detail
        11.7.2 Tesaro Business Overview
        11.7.3 Tesaro Cancer Supportive Care Drugs Introduction
        11.7.4 Tesaro Revenue in Cancer Supportive Care Drugs Business (2017-2022)
        11.7.5 Tesaro Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Cancer Supportive Care Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of G-CSFs (Granulocyte-colony Stimulating Factors) Table 3. Key Players of ESAs (Erythropoiesis Stimulating Agents) Table 4. Key Players of Anti-emetics Table 5. Key Players of Bisphosphonates Table 6. Key Players of Opioids Table 7. Key Players of NSAIDs Table 8. Global Cancer Supportive Care Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Cancer Supportive Care Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Cancer Supportive Care Drugs Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Cancer Supportive Care Drugs Market Share by Region (2017-2022) Table 12. Global Cancer Supportive Care Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Cancer Supportive Care Drugs Market Share by Region (2023-2028) Table 14. Cancer Supportive Care Drugs Market Trends Table 15. Cancer Supportive Care Drugs Market Drivers Table 16. Cancer Supportive Care Drugs Market Challenges Table 17. Cancer Supportive Care Drugs Market Restraints Table 18. Global Cancer Supportive Care Drugs Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Cancer Supportive Care Drugs Market Share by Players (2017-2022) Table 20. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Supportive Care Drugs as of 2021) Table 21. Ranking of Global Top Cancer Supportive Care Drugs Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Cancer Supportive Care Drugs Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Cancer Supportive Care Drugs Product Solution and Service Table 25. Date of Enter into Cancer Supportive Care Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Cancer Supportive Care Drugs Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2017-2022) Table 29. Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2023-2028) Table 31. Global Cancer Supportive Care Drugs Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2017-2022) Table 33. Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2023-2028) Table 35. North America Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million) Table 45. Amgen Company Detail Table 46. Amgen Business Overview Table 47. Amgen Cancer Supportive Care Drugs Product Table 48. Amgen Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million) Table 49. Amgen Recent Development Table 50. Johnson & Johnson Company Detail Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Cancer Supportive Care Drugs Product Table 53. Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million) Table 54. Johnson & Johnson Recent Development Table 55. Merck Company Detail Table 56. Merck Business Overview Table 57. Merck Cancer Supportive Care Drugs Product Table 58. Merck Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million) Table 59. Merck Recent Development Table 60. Roche Company Detail Table 61. Roche Business Overview Table 62. Roche Cancer Supportive Care Drugs Product Table 63. Roche Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million) Table 64. Roche Recent Development Table 65. Helsinn Healthcare Company Detail Table 66. Helsinn Healthcare Business Overview Table 67. Helsinn Healthcare Cancer Supportive Care Drugs Product Table 68. Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million) Table 69. Helsinn Healthcare Recent Development Table 70. Heron Pharma Company Detail Table 71. Heron Pharma Business Overview Table 72. Heron Pharma Cancer Supportive Care Drugs Product Table 73. Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million) Table 74. Heron Pharma Recent Development Table 75. Tesaro Company Detail Table 76. Tesaro Business Overview Table 77. Tesaro Cancer Supportive Care Drugs Product Table 78. Tesaro Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million) Table 79. Tesaro Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Supportive Care Drugs Market Share by Type: 2021 VS 2028 Figure 2. G-CSFs (Granulocyte-colony Stimulating Factors) Features Figure 3. ESAs (Erythropoiesis Stimulating Agents) Features Figure 4. Anti-emetics Features Figure 5. Bisphosphonates Features Figure 6. Opioids Features Figure 7. NSAIDs Features Figure 8. Global Cancer Supportive Care Drugs Market Share by Application in 2021 & 2028 Figure 9. Chemotherapy Therapy Case Studies Figure 10. Radiation Therapy Case Studies Figure 11. Cancer Supportive Care Drugs Report Years Considered Figure 12. Global Cancer Supportive Care Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Cancer Supportive Care Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Cancer Supportive Care Drugs Market Share by Region: 2021 VS 2028 Figure 15. Global Cancer Supportive Care Drugs Market Share by Players in 2021 Figure 16. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Supportive Care Drugs as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Cancer Supportive Care Drugs Revenue in 2021 Figure 18. North America Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Cancer Supportive Care Drugs Market Share by Country (2017-2028) Figure 20. United States Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Cancer Supportive Care Drugs Market Share by Country (2017-2028) Figure 24. Germany Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Cancer Supportive Care Drugs Market Share by Region (2017-2028) Figure 32. China Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Cancer Supportive Care Drugs Market Share by Country (2017-2028) Figure 40. Mexico Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Cancer Supportive Care Drugs Market Share by Country (2017-2028) Figure 44. Turkey Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Amgen Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022) Figure 47. Johnson & Johnson Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022) Figure 48. Merck Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022) Figure 49. Roche Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022) Figure 50. Helsinn Healthcare Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022) Figure 51. Heron Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022) Figure 52. Tesaro Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us